Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio
May 14th, 2018 – Milan (Italy) – Axxam is proud to announce that Acousia Therapeutics (Tubingen; Germany), a biotech company participated by Axxam and focused to develop therapies for the treatment of hearing loss, raised €10 Million in Series B Financing round. The financing was led by new investor LBBW Venture Capital, and joined by other new investors, Creathor Ventures and Bregua Corporation. Existing investors, Boehringer Ingelheim Venture Fund (BIVF) and Kreditanstalt für Wiederaufbau (KfW) also participated in the round. For more info please open the Press Release from Acousia Therapeutics.